Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 2.04TCr 302.46Cr 261.24Cr 245.79Cr 223.39Cr 420.16Cr 29TCr 426.32Cr 2.88TCr 1.13TCr 14TCr 1.14TCr 1.11TCr 48TCr P/E 2026 *
13.7x
P/E 2027 * 11.9x
Enterprise Value 1.69TCr 250.28Cr 216.16Cr 203.38Cr 184.85Cr 347.67Cr 24TCr 352.76Cr 2.39TCr 934.96Cr 12TCr 939.66Cr 919.26Cr 40TCr EV / Sales 2026 *
0.56x
EV / Sales 2027 * 0.5x
Free-Float
34.77%
Yield 2026 *
5.03%
Yield 2027 * 5.54%
1 day+0.79%
1 week-1.76%
Current month-4.99%
1 month-3.55%
3 months-4.78%
6 months-6.82%
Current year+1.65%
1 week 17.51
Extreme 17.51
19.23
1 month 17.41
Extreme 17.41
19.99
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
28.35
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 28/02/2019
Director of Finance/CFO 44 10/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 16/07/2013
Director/Board Member 63 08/08/2016
Chairman 48 28/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
+0.79%-1.76%+5.11%-37.86% 300.21Cr
-1.58%-3.94%-37.14%-18.60% 1.59TCr
-0.76%-11.07%-38.93%-32.89% 675.84Cr
+0.40%-2.70%-22.70%-16.28% 611.53Cr
0.00%+2.43%+2.70%-25.81% 431.64Cr
-0.05%-3.48%-19.87%-40.26% 322.02Cr
-0.67%-3.16%-44.22%-23.79% 302.59Cr
+0.19%+0.06%-12.89%-2.10% 264.33Cr
+0.74%-2.99%+54.23% - 240.7Cr
-0.03%0.00%-8.01%+27.51% 158.83Cr
Average -0.10%-3.04%-12.17%-18.90% 489.81Cr
Weighted average by Cap. -0.52%-3.45%-22.04%-21.61%

Financials

2026 *2027 *
Net sales 2.99TCr 443.47Cr 383.02Cr 360.38Cr 327.53Cr 616.04Cr 42TCr 625.07Cr 4.23TCr 1.66TCr 21TCr 1.67TCr 1.63TCr 71TCr 3.3TCr 489.83Cr 423.07Cr 398.05Cr 361.78Cr 680.45Cr 47TCr 690.42Cr 4.67TCr 1.83TCr 23TCr 1.84TCr 1.8TCr 78TCr
Net income 148.46Cr 22Cr 19Cr 18Cr 16Cr 31Cr 2.11TCr 31Cr 209.85Cr 82Cr 1.05TCr 83Cr 81Cr 3.51TCr 171.45Cr 25Cr 22Cr 21Cr 19Cr 35Cr 2.44TCr 36Cr 242.35Cr 95Cr 1.22TCr 95Cr 93Cr 4.06TCr
Net Debt -351.92Cr -52Cr -45Cr -42Cr -39Cr -72Cr -5TCr -74Cr -497.45Cr -194.95Cr -2.5TCr -195.93Cr -191.68Cr -8.33TCr -400.97Cr -59Cr -51Cr -48Cr -44Cr -83Cr -5.7TCr -84Cr -566.79Cr -222.12Cr -2.85TCr -223.24Cr -218.4Cr -9.49TCr
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
18/26/18 CN¥17.91 +0.79% 57,25,320
17/26/17 CN¥17.77 -0.78% 79,65,480
14/26/14 CN¥17.91 -0.17% 80,12,677
13/26/13 CN¥17.94 -1.10% 77,17,365
12/26/12 CN¥18.14 -3.82% 1,25,79,939
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
17.91CNY
Average target price
24.70CNY
Spread / Average Target
+37.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock